Senate File 2372 - Introduced


                                 SENATE FILE 

                                 SENATE FILE 
                                 SENATE FILE                                  SENATE FILE                                  BY  COMMITTEE ON JUDICIARY

                                 (SUCCESSOR TO SSB
                                     3135)

 A BILL FOR

  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis 
                                 (SUCCESSOR TO SSB
                                     3135)

 A BILL FOR

  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis                                  (SUCCESSOR TO SSB
                                     3135)

 A BILL FOR

  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis                                      3135)

 A BILL FOR

  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis 
 A BILL FOR

  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis  A BILL FOR

  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis 
  1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1 An Act relating to the regulation of medical cannabidiol, by
  2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   2    altering the list of debilitating medical conditions and
  3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   3    changing the definition of medical cannabidiol under the
  4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   4    medical cannabidiol Act, and exempting sales of medical
  5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   5    cannabidiol products from Iowa sales tax.
  6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   6 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis     TLSB 6120SV (1) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis     ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis 

  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis 
  1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  1    Section 1.  Section 124E.2, subsections 2 and 6, Code 2018,
  1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  2 are amended to read as follows:
  1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  3    2.  "Debilitating medical condition" means any of the
  1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  4 following:
  1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  5    a.  Cancer, if the underlying condition or treatment produces
  1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  6 one or more of the following:
  1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  7    (1)  Severe or chronic pain.
  1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  8    (2)  Nausea or severe vomiting.
  1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1  9    (3)  Cachexia or severe wasting.
  1 10    b.  Multiple sclerosis   1 10    b.  Multiple sclerosis   1 11 spasms  1 12    c.  Seizures, including those characteristic of epilepsy.
  1 13    d.  AIDS or HIV as defined in section 141A.1.
  1 14    e.  Crohn's disease.
  1 15    f.  Amyotrophic lateral sclerosis.
  1 16    g.  Any terminal illness, with a probable life expectancy of
  1 17 under one year, if the illness or its treatment produces one or
  1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 13    d.  AIDS or HIV as defined in section 141A.1.
  1 14    e.  Crohn's disease.
  1 15    f.  Amyotrophic lateral sclerosis.
  1 16    g.  Any terminal illness, with a probable life expectancy of
  1 17 under one year, if the illness or its treatment produces one or
  1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 14    e.  Crohn's disease.
  1 15    f.  Amyotrophic lateral sclerosis.
  1 16    g.  Any terminal illness, with a probable life expectancy of
  1 17 under one year, if the illness or its treatment produces one or
  1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 15    f.  Amyotrophic lateral sclerosis.
  1 16    g.  Any terminal illness, with a probable life expectancy of
  1 17 under one year, if the illness or its treatment produces one or
  1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 16    g.  Any terminal illness, with a probable life expectancy of
  1 17 under one year, if the illness or its treatment produces one or
  1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 17 under one year, if the illness or its treatment produces one or
  1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 18 more of the following:
  1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 19    (1)  Severe or chronic pain.
  1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 20    (2)  Nausea or severe vomiting.
  1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 21    (3)  Cachexia or severe wasting.
  1 22    h.  Parkinson's disease.
  1 23    i.    1 22    h.  Parkinson's disease.
  1 23    i.    1 23    i.    1 24      1 25 health care practitioner determines the use of medical
  1 26 cannabidiol could be medically beneficial.  1 26 cannabidiol could be medically beneficial.  1 27    6.  "Medical cannabidiol" means any   1 28 grade  1 29 Cannabis indica or any other preparation thereof   1 30 a tetrahydrocannabinol level of no more than three percent
  1 31 and  1 31 and  1 32 cannabidiol board, approved by the board of medicine, and
  1 33 adopted by the department pursuant to rule.
  1 34    Sec. 2.  Section 124E.2, subsection 8, Code 2018, is amended
  1 35 by striking the subsection.
  2  1    Sec. 3.  Section 124E.3, subsection 1, paragraph a, Code
  2  2 2018, is amended to read as follows:
  2  3    a.    1 33 adopted by the department pursuant to rule.
  1 34    Sec. 2.  Section 124E.2, subsection 8, Code 2018, is amended
  1 35 by striking the subsection.
  2  1    Sec. 3.  Section 124E.3, subsection 1, paragraph a, Code
  2  2 2018, is amended to read as follows:
  2  3    a.    1 34    Sec. 2.  Section 124E.2, subsection 8, Code 2018, is amended
  1 35 by striking the subsection.
  2  1    Sec. 3.  Section 124E.3, subsection 1, paragraph a, Code
  2  2 2018, is amended to read as follows:
  2  3    a.    1 35 by striking the subsection.
  2  1    Sec. 3.  Section 124E.3, subsection 1, paragraph a, Code
  2  2 2018, is amended to read as follows:
  2  3    a.    2  1    Sec. 3.  Section 124E.3, subsection 1, paragraph a, Code
  2  2 2018, is amended to read as follows:
  2  3    a.    2  2 2018, is amended to read as follows:
  2  3    a.    2  3    a.    2  4 judgment, whether the patient whom the health care practitioner
  2  5 has examined and treated suffers from a debilitating medical
  2  6 condition that qualifies for the use of medical cannabidiol
  2  7 under this chapter, and if so determined, provide the patient
  2  8 with a written certification of that diagnosis.
  2  9      2  5 has examined and treated suffers from a debilitating medical
  2  6 condition that qualifies for the use of medical cannabidiol
  2  7 under this chapter, and if so determined, provide the patient
  2  8 with a written certification of that diagnosis.
  2  9      2  6 condition that qualifies for the use of medical cannabidiol
  2  7 under this chapter, and if so determined, provide the patient
  2  8 with a written certification of that diagnosis.
  2  9      2  7 under this chapter, and if so determined, provide the patient
  2  8 with a written certification of that diagnosis.
  2  9      2  8 with a written certification of that diagnosis.
  2  9      2  9      2 10 patient whom the health care practitioner has examined and
  2 11 treated suffers from a debilitating medical condition pursuant
  2 12 to section 124E.2, subsection 2, paragraph "j", that qualifies
  2 13 for the use of medical cannabidiol under this chapter, the
  2 14 health care practitioner's written certification shall be based
  2 15 on reasonable medical evidence, and shall be made in good
  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 11 treated suffers from a debilitating medical condition pursuant
  2 12 to section 124E.2, subsection 2, paragraph "j", that qualifies
  2 13 for the use of medical cannabidiol under this chapter, the
  2 14 health care practitioner's written certification shall be based
  2 15 on reasonable medical evidence, and shall be made in good
  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 12 to section 124E.2, subsection 2, paragraph "j", that qualifies
  2 13 for the use of medical cannabidiol under this chapter, the
  2 14 health care practitioner's written certification shall be based
  2 15 on reasonable medical evidence, and shall be made in good
  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 13 for the use of medical cannabidiol under this chapter, the
  2 14 health care practitioner's written certification shall be based
  2 15 on reasonable medical evidence, and shall be made in good
  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 14 health care practitioner's written certification shall be based
  2 15 on reasonable medical evidence, and shall be made in good
  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 15 on reasonable medical evidence, and shall be made in good
  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 16 faith, in the best interest of the patient, without fraudulent
  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 17 intent, and with the same reasonable medical judgment and
  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 18 prudence exercised according to generally accepted medical
  2 19 practice.  2 19 practice.  2 20    Sec. 4.  Section 124E.5, subsection 6, Code 2018, is amended
  2 21 by striking the subsection.
  2 22    Sec. 5.  Section 423.3, Code 2018, is amended by adding the
  2 23 following new subsection:
  2 24      2 21 by striking the subsection.
  2 22    Sec. 5.  Section 423.3, Code 2018, is amended by adding the
  2 23 following new subsection:
  2 24      2 22    Sec. 5.  Section 423.3, Code 2018, is amended by adding the
  2 23 following new subsection:
  2 24      2 23 following new subsection:
  2 24      2 24      2 25 cannabidiol product sold by a medical cannabidiol manufacturer
  2 26 or a medical cannabidiol dispensary pursuant to chapter 124E.
  2 27                           EXPLANATION
  2 28 The inclusion of this explanation does not constitute agreement with
  2 29 the explanation's substance by the members of the general assembly.
  2 30    This bill relates to the regulation of medical cannabidiol.
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 26 or a medical cannabidiol dispensary pursuant to chapter 124E.
  2 27                           EXPLANATION
  2 28 The inclusion of this explanation does not constitute agreement with
  2 29 the explanation's substance by the members of the general assembly.
  2 30    This bill relates to the regulation of medical cannabidiol.
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 27                           EXPLANATION
  2 28 The inclusion of this explanation does not constitute agreement with
  2 29 the explanation's substance by the members of the general assembly.
  2 30    This bill relates to the regulation of medical cannabidiol.
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 28 The inclusion of this explanation does not constitute agreement with
  2 29 the explanation's substance by the members of the general assembly.
  2 30    This bill relates to the regulation of medical cannabidiol.
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 29 the explanation's substance by the members of the general assembly.
  2 30    This bill relates to the regulation of medical cannabidiol.
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 30    This bill relates to the regulation of medical cannabidiol.
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 31    The bill amends the definition of "debilitating medical
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 32 condition" under the medical cannabidiol Act (Code chapter
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 33 124E) by removing the requirement that multiple sclerosis be
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 34 accompanied by severe and persistent muscle spasms, replacing
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  2 35 the term "untreatable pain" with "severe or chronic pain", and
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  1 including any medical condition for which a patient's health
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  2 care practitioner determines the use of medical cannabidiol
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  3 could be medically beneficial.
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  4    The bill requires that any certification made by a health
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  5 care practitioner for a patient for a debilitating medical
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  6 condition not explicitly included on the list of debilitating
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  7 medical conditions shall be made by a health care practitioner
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  8 pursuant to reasonable medical evidence, in good faith, in
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3  9 the best interest of the patient, without fraudulent intent,
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 10 and with the same reasonable medical judgment and prudence
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 11 exercised according to generally accepted medical practice.
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 12 Under current law, a health care practitioner may only issue
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 13 a written certification for a debilitating medical condition
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 14 explicitly included on the list of debilitating medical
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 15 conditions. A written certification may be renewed on an
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 16 annual basis if the health care practitioner determines that
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 17 the patient continues to suffer from the debilitating medical
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 18 condition.
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 19    The bill alters the definition of medical cannabidiol by
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 20 removing the requirements that medical cannabidiol be any
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 21 pharmaceutical grade cannabinoid and that the cannabinoid has a
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 22 tetrahydrocannabinol (THC) level of 3 percent or less.
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 23    The bill exempts sales of medical cannabidiol products by
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 24 a medical cannabidiol manufacturer or a medical cannabidiol
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
  3 25 dispensary pursuant to Code chapter 124E from sales tax.
       LSB 6120SV (1) 87
       ss/rh
       LSB 6120SV (1) 87
       ss/rh
       ss/rh
